Share on LinkedInShare on LinkedIn

ARTICLE · 19 MAY 2020

Assignor Estoppel Does Not Prevent Reliance On PTAB Decision Canceling Claims

In Hologic, Inc. v. Minerva Surgical, Inc., Case 19-2054 (Fed. Cir. Apr. 22, 2020), the Federal Circuit held that an assignor of a patent may rely on a PTAB unpatentability decision as a defense in infringement litigation,...

United StatesIntellectual Property

In Hologic, Inc. v. Minerva Surgical, Inc., Case 19-2054 (Fed. Cir. Apr. 22, 2020), the Federal Circuit held that an assignor of a patent may rely on a PTAB unpatentability decision as a defense in infringement litigation, although the equitable doctrine of "assignor estoppel" prevents the assignor from directly challenging validity in the litigation. In Additional Views, Judge Stoll suggests that the en banc court reconsider the issue of assignor estoppel, because the court's precedent permits an assignor of a patent to "circumvent the doctrine of assignor estoppel by attacking the validity of a patent claim in the Patent Office."

Hologic sued Minerva Surgical for infringement of two patents directed to devices used to detect perforations in a patient's uterus (U.S. Patent Nos. 6,872,183 and 9,095,348). Minerva denied infringement, and also raised invalidity defenses, both in the district court proceeding and in two IPR petitions. Minerva's President and CEO was

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from